Suramins and suradistas, an important group of potential anti-cancer agents
, inhibit fibroblast growth factor (FGF) mitogenic activity. It has been sh
own that naphthalenesulfonates, with a common chemical function to the fami
ly of suramins and suradistas, mimic their inhibitory activity, abolishing
FGF-induced angiogenesis in vivo, and inducing apoptosis of C6 glioma cells
in culture. In the present report, we show that intratumoral administratio
n of 1-naphthalenemonosulfonate induces a considerable regression of glioma
s in rats, significantly enhances apoptosis, and attenuates tumor angiogene
sis. These findings may lead to new approaches for the treatment of gliobla
stoma, a most common primary malignant brain tumor of very poor prognosis,
as well as of other angiogenesis-dependent malignancies. (C) 2001 Elsevier
Science Ireland Ltd. All rights reserved.